Andrew Wardley: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Adjuvant trastuzumab duration trials in HER2 positive breast cancer – what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results

Hiller, Louise, Dunn, Janet A., Loi, Shrushma, Vallier, Anne-Laure, Howe, Donna L., Cameron, David A., Miles, David, Wardley, Andrew M., Earl, Helena M.

Journal:

Year:

2018

Language:

english

File:

PDF, 889 KB

english, 2018

2

Impact of skeletal complications on patients’ quality of life, mobility, and functional independence

Luis Costa, Xavier Badia, Edward Chow, Allan Lipton, Andrew Wardley

Journal:

Supportive Care in Cancer

Year:

2008

Language:

english

File:

PDF, 294 KB

english, 2008

3

Facilitating reproductive choices: the impact of health services on the experiences of young women with breast cancer

Rebecca J. Lee, Ann Wakefield, Sharon Foy, Sacha J. Howell, Andrew M. Wardley, Anne C. Armstrong

Journal:

Psycho-Oncology

Year:

2011

Language:

english

File:

PDF, 144 KB

english, 2011

4

Impact of skeletal complications on patients’ quality of life, mobility, and functional independence

Luis Costa, Xavier Badia, Edward Chow, Allan Lipton, Andrew Wardley

Journal:

Supportive Care in Cancer

Year:

2008

Language:

english

File:

PDF, 40 KB

english, 2008

5

A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy

Stephen R. D. Johnston, Vladimir F. Semiglazov, George M. Manikhas, Dominique Spaeth, Gilles Romieu, David J. Dodwell, Andrew M. Wardley, Patrick Neven, Annick Bessems, Youn C. Park, Peter M. De Porre

Journal:

Breast Cancer Research and Treatment

Year:

2008

Language:

english

File:

PDF, 180 KB

english, 2008

6

Detection ofPIK3CAmutations in circulating free DNA in patients with breast cancer

Ruth E. Board, Andrew M. Wardley, J. Michael Dixon, Anne C. Armstrong, Sacha Howell, Lorna Renshaw, Emma Donald, Alastair Greystoke, Malcolm Ranson, Andrew Hughes, Caroline Dive

Journal:

Breast Cancer Research and Treatment

Year:

2010

Language:

english

File:

PDF, 255 KB

english, 2010

7

Understanding the BIG results: Insights from the BIG 1–98 trial analyses

Andrew M. Wardley

Journal:

Advances in Therapy

Year:

2008

Language:

english

File:

PDF, 1.71 MB

english, 2008

8

Polymorphisms ofCYP19A1and response to aromatase inhibitors in metastatic breast cancer patients

Roberta Ferraldeschi, Monica Arnedos, Kristen D. Hadfield, Roger A’Hern, Suzie Drury, Andrew Wardley, Anthony Howell, D. Gareth Evans, Stephen A. Roberts, Ian Smith, William G. Newman, Mitch Dowsett

Journal:

Breast Cancer Research and Treatment

Year:

2012

Language:

english

File:

PDF, 295 KB

english, 2012

9

The need for advanced breast cancer treatment guidelines: Results of an internet-based survey

Journal:

Year:

2008

Language:

english

File:

PDF, 155 KB

english, 2008

10

LHRH agonists are more effective when combined with tamoxifen for advanced premenopausal breast cancer

N. Bundred, Andrew Wardley

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 81 KB

english, 2002

11

Emerging Data on Optimal Adjuvant Endocrine Therapy: Breast International Group Trial 1-98/MA.17

Andrew M. Wardley

Journal:

Clinical Breast Cancer

Year:

2006

Language:

english

File:

PDF, 99 KB

english, 2006

12

Fulvestrant (‘Faslodex’): Clinical experience from the Compassionate Use Programme

Guenther G. Steger, Maya Gips, Sergio D. Simon, Ana Lluch, Jefferson Vinholes, Bella Kaufman, Andrew Wardley, Louis Mauriac

Journal:

Cancer Treatment Reviews

Year:

2005

Language:

english

File:

PDF, 109 KB

english, 2005

13

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

Paul Ellis, Peter Barrett-Lee, Lindsay Johnson, David Cameron, Andrew Wardley, Susan O'Reilly, Mark Verrill, Ian Smith, John Yarnold, Robert Coleman, Helena Earl, Peter Canney, Chris Twelves, Christop

Journal:

Year:

2009

Language:

english

File:

PDF, 290 KB

english, 2009

14

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Andrew Tutt, Mark Robson, Judy E Garber, Susan M Domchek, M William Audeh, Jeffrey N Weitzel, Michael Friedlander, Banu Arun, Niklas Loman, Rita K Schmutzler, Andrew Wardley, Gillian Mitchell, Helena

Journal:

Year:

2010

Language:

english

File:

PDF, 594 KB

english, 2010

15

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Meredith M Regan, Patrick Neven, Anita Giobbie-Hurder, Aron Goldhirsch, Bent Ejlertsen, Louis Mauriac, John F Forbes, Ian Smith, István Láng, Andrew Wardley, Manuela Rabaglio, Karen N Price, Richard D

Journal:

The Lancet Oncology

Year:

2011

Language:

english

File:

PDF, 287 KB

english, 2011

16

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

John R Mackey, Miguel Martin, Tadeusz Pienkowski, Janusz Rolski, Jean-Paul Guastalla, Amer Sami, John Glaspy, Eva Juhos, Andrew Wardley, Tommy Fornander, John Hainsworth, Robert Coleman, Manuel R Modi

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 340 KB

english, 2013

17

Does HER2 overexpression affect response to endocrine therapy in advanced cancer?

Wardley, Andrew M, Howell, Anthony

Journal:

Nature Clinical Practice Oncology

Year:

2006

Language:

english

File:

PDF, 88 KB

english, 2006

18

A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer

Rugo, Hope S., Campone, Mario, Amadori, Dino, Aldrighetti, Daniela, Conte, PierFranco, Wardley, Andrew, Villanueva, Cristian, Melisko, Michelle, McHenry, M. Brent, Liu, David, Lee, Francis, Pivot, Xav

Journal:

Breast Cancer Research and Treatment

Year:

2013

Language:

english

File:

PDF, 333 KB

english, 2013

19

PERSEPHONE is a randomised phase III controlled trial comparing six months of trastuzumab to the standard 12 months in patients with HER2 positive early breast cancer

Earl, Helena, Cameron, David, Miles, David, Wardley, Andrew, Ogburn, Emma, Vallier, Anne-Laure, Loi, Shrushma, Hiller, Louise, Dunn, Janet

Journal:

European Journal of Surgical Oncology (EJSO)

Year:

2014

Language:

english

File:

PDF, 40 KB

english, 2014

20

21. Experience with the oncotype DX Assay in a UK centre

Bundred, Nigel, Armstrong, Anne, Howell, Sacha, Wardley, Andrew, Wilson, Gavin, Loncaster, Juliette, Welch, Richard, Ooi, Jane, Chittalia, Abbas, Barr, Lester

Journal:

European Journal of Surgical Oncology (EJSO)

Year:

2014

Language:

english

File:

PDF, 54 KB

english, 2014

21

CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)

Pestalozzi, Bernhard C, Holmes, Eileen, de Azambuja, Evandro, Metzger-Filho, Otto, Hogge, Laurence, Scullion, Matt, Láng, István, Wardley, Andrew, Lichinitser, Mikhail, Sanchez, Roberto I Lopez, Mülle

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 198 KB

english, 2013

22

Second-line treatment of postmenopausal women with advanced breast carcinoma

Board, Ruth E, Dean, Emma J, Mitchell, Claire, Wardley, Andrew M

Journal:

Expert Review of Anticancer Therapy

Year:

2006

Language:

english

File:

PDF, 142 KB

english, 2006

23

Trastuzumab-associated cardiac events in the Persephone trial

Earl, Helena M, Vallier, Anne-Laure, Dunn, Janet, Loi, Shrushma, Ogburn, Emma, McAdam, Karen, Hughes-Davies, Luke, Harnett, Adrian, Abraham, Jean, Wardley, Andrew, Cameron, David A, Miles, David, Goun

Journal:

British Journal of Cancer

Year:

2016

Language:

english

File:

PDF, 269 KB

english, 2016

24

Letrozole: advancing hormone therapy in breast cancer

Lee, Rebecca J, Armstrong, Anne C, Wardley, Andrew M

Journal:

Year:

2012

Language:

english

File:

PDF, 656 KB

english, 2012

25

A Phase II Study of Talazoparib After Platinum or Cytotoxic Nonplatinum Regimens in Patients With Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO)

Turner, Nicholas C., Telli, Melinda L., Rugo, Hope S., Mailliez, Audrey, Ettl, Johannes, Grischke, Eva-Maria, Mina, Lida A., Balmaña, Judith, Fasching, Peter A., Hurvitz, Sara A., Wardley, Andrew M.,

Journal:

Clinical Cancer Research

Year:

2018

Language:

english

File:

PDF, 460 KB

english, 2018

26

Emerging targeted combinations in the management of breast cancer

Wardley, Andrew, Lee,, Armstrong,

Journal:

Breast Cancer Targets and Therapy

Year:

2013

File:

PDF, 451 KB

2013

27

Protective strategies to prevent trastuzumab-induced cardiotoxicity â Authors' reply

Earl, Helena M, Hiller, Louise, Plummer, Chris, Miles, David, Wardley, Andrew M, Cameron, David A, Dunn, Janet A

Journal:

Lancet (London, England)

Year:

2020

File:

PDF, 142 KB

2020

28

Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial

Tolaney, Sara M, Wardley, Andrew M, Zambelli, Stefania, Hilton, John F, Troso-Sandoval, Tiffany A, Ricci, Francesco, Im, Seock-Ah, Kim, Sung-Bae, Johnston, Stephen RD, Chan, Arlene, Goel, Shom, Catron

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 783 KB

2020

29

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

Turner, Nicholas C, Kingston, Belinda, Kilburn, Lucy S, Kernaghan, Sarah, Wardley, Andrew M, Macpherson, Iain R, Baird, Richard D, Roylance, Rebecca, Stephens, Peter, Oikonomidou, Olga, Braybrooke, Je

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 1.67 MB

2020

30

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

Rabaglio, Manuela, Sun, Zhuoxin, Maibach, Rudolf, Giobbie-Hurder, Anita, Ejlertsen, Bent, Harvey, Vernon J., Neven, Patrick, LÃ¡ng, IstvÃ¡n, Bonnefoi, HervÃ©, Wardley, Andrew, Ruepp, Barbara, Castigli

Journal:

Breast Cancer Research and Treatment

Year:

2020

File:

PDF, 536 KB

2020

31

Health-related quality of life and work productivity in UK patients with HER2-positive breast cancer: a cross-sectional study evaluating the relationships between disease and treatment stage

Verrill, Mark, Wardley, Andrew M., Retzler, Jenny, Smith, Adam B., Bottomley, Catherine, NÃ Dhochartaigh, Sorcha, Tran, Irwin, Leslie, Iain, Schmid, Peter

Journal:

Health and Quality of Life Outcomes

Year:

2020

File:

PDF, 1006 KB

2020

32

Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literature

Thanopoulou, Eirini, Khader, Leila, Caira, Morena, Wardley, Andrew, Ettl, Johannes, Miglietta, Federica, Neven, Patrick, Guarneri, Valentina

Journal:

Year:

2020

File:

PDF, 1.29 MB

2020